Financial Ratios

CORAL LABORATORIES LTD.

NSE : NABSE : 524506ISIN CODE : INE683E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE383.953.9 (+1.03 %)
PREV CLOSE ( ) 380.05
OPEN PRICE ( ) 380.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3566
TODAY'S LOW / HIGH ( )375.50 390.00
52 WK LOW / HIGH ( ) 225498.1
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)18.0425.3237.9419.9628.60
   CEPS(Rs)24.1430.8943.4925.5833.92
   DPS(Rs)0.000.000.000.002.00
   Book NAV/Share(Rs)433.29436.81382.48323.77318.45
   Tax Rate(%)21.6523.7023.0421.7934.11
Margin Ratios
   Core EBITDA Margin(%)4.8810.8616.417.6813.64
   EBIT Margin(%)10.9615.8718.2813.1917.21
   Pre Tax Margin(%)10.5315.6818.2412.9217.02
   PAT Margin (%)8.2511.9614.0410.1011.22
   Cash Profit Margin (%)11.0414.6016.0912.9513.31
Performance Ratios
   ROA(%)3.545.068.695.097.40
   ROE(%)4.156.1810.746.228.88
   ROCE(%)5.417.8713.357.8613.44
   Asset Turnover(x)0.430.420.620.500.66
   Sales/Fixed Asset(x)1.641.742.361.772.40
   Working Capital/Sales(x)0.700.720.961.001.39
Efficiency Ratios
   Fixed Capital/Sales(x)0.610.580.420.560.42
   Receivable days143.76186.51139.03167.38124.10
   Inventory Days72.1196.6477.4391.7267.57
   Payable days75.80167.30164.79181.18144.27
Valuation Parameters
   PER(x)12.6910.088.494.9111.06
   PCE(x)9.488.267.413.839.32
   Price/Book(x)0.530.580.840.300.99
   Yield(%)0.000.000.000.000.63
   EV/Net Sales(x)0.530.790.900.151.00
   EV/Core EBITDA(x)3.864.594.410.975.21
   EV/EBIT(x)4.834.984.901.175.84
   EV/CE(x)0.240.310.520.080.67
   M Cap / Sales1.051.211.190.501.24
Growth Ratio
   Net Sales Growth(%)3.32-21.7036.82-22.51-1.51
   Core EBITDA Growth(%)-17.82-33.6073.39-35.62-11.29
   EBIT Growth(%)-28.61-32.0589.67-40.61-14.12
   PAT Growth(%)-28.75-33.2690.10-30.21-17.91
   EPS Growth(%)-28.75-33.2690.10-30.21-17.91
Financial Stability Ratios
   Total Debt/Equity(x)0.000.040.050.050.01
   Current Ratio(x)10.425.134.673.824.64
   Quick Ratio(x)9.364.413.883.053.74
   Interest Cover(x)25.3085.02415.4148.6893.80
   Total Debt/Mcap(x)0.000.070.050.170.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.